headline
RSV protection starts with Pfizer's ABRYSVO® (Respiratory Syncytial Virus Vaccine)
content
Respiratory syncytial virus (RSV) is a highly contagious virus that can lead to serious health consequences.
Card_identifier
mobile_image
image_caption
Actor portrayal
heading
Adults 50 years and older
body
Pfizer’s ABRYSVO is a vaccine to prevent respiratory disease from RSV. It is recommended for adults aged 75+ years and 50 to 74 with certain chronic conditions.
Card_identifier
mobile_image
image_caption
Actor portrayal
heading
Pregnant women to protect their baby
body
Pfizer's ABRYSVO is the only RSV vaccine given during pregnancy from 32 through 36 weeks that helps protect your baby against respiratory disease caused by RSV, from birth through 6 months.